E-LIB Suche - Ergebnisse für: Veruttipong, D.

1

Functional Outcomes after De-escalated Chemoradiation for H..:

Hegde, J.V. ; Shaverdian, N. ; Felix, C....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. S42 , 2017

Link: https://doi.org/10.1016/..

2

Prognostic Significance of FDG-PET Metabolic Tumor Paramete..:

Velez, M.A. ; Veruttipong, D. ; Abemayor, E....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E379 , 2017

Link: https://doi.org/10.1016/..

3

Impact of Prior Radiation Therapy on the Efficacy and Toxic..:

Shaverdian, N. ; Lisberg, A.E. ; Bornazyan, K....
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. S151 , 2017

Link: https://doi.org/10.1016/..

4

Prostate Cancer Antigen 3 Score Does Not Predict for Advers..:

Hegde, J.V. ; Veruttipong, D. ; Reiter, R.E...
International Journal of Radiation Oncology*Biology*Physics. 99 (2017) 2 - p. E238 , 2017

Link: https://doi.org/10.1016/..

5

Combined Pretreatment Serum Testosterone Concentration and ..:

Wang, J. ; Zhao, D. ; Veruttipong, D....
International Journal of Radiation Oncology*Biology*Physics. 96 (2016) 2 - p. E283-E284 , 2016

Link: https://doi.org/10.1016/..

6

Discrepancies in Accelerated Partial Breast Irradiation (AP..:

Kuske, R.R. ; Demanes, J. ; Anderson, B.M....
International Journal of Radiation Oncology*Biology*Physics. 96 (2016) 2 - p. E53-E54 , 2016

Link: https://doi.org/10.1016/..

7

Exploring Value From the Patient's Perspective Between Ster..:

Shaverdian, N. ; Demanes, J. ; Veruttipong, D....
International Journal of Radiation Oncology*Biology*Physics. 96 (2016) 2 - p. E238 , 2016

Link: https://doi.org/10.1016/..

8

SU‐F‐T‐102: Automatic Curation for a Scalable Registry Usin..:

Ruan, D ; Shao, W ; Wong, J...
Medical Physics. 43 (2016) 6Part14 - p. 3485-3485 , 2016

Link: https://doi.org/10.1118/..

9

Location, Location, Location: Lower Lobe Stage I Non-Small ..:

Shaverdian, N. ; Veruttipong, D. ; Wang, J....
International Journal of Radiation Oncology*Biology*Physics. 96 (2016) 2 - p. E427 , 2016

Link: https://doi.org/10.1016/..

10

Reirradiation for Recurrent and New Primary Head and Neck C..:

Velez, M.A. ; Rwigema, J.C. ; Veruttipong, D....
International Journal of Radiation Oncology*Biology*Physics. 94 (2016) 4 - p. 933 , 2016

Link: https://doi.org/10.1016/..

11

Pretreatment Anemia Portends Poor Outcomes in Stage I Non-S..:

Shaverdian, N. ; Veruttipong, D. ; Wang, J....
International Journal of Radiation Oncology*Biology*Physics. 96 (2016) 2 - p. E427 , 2016

Link: https://doi.org/10.1016/..

12

Clinical Outcomes in Unresectable Cholangiocarcinoma Treate..:

Sandler, K.A. ; Veruttipong, D. ; Agopian, V....
International Journal of Radiation Oncology*Biology*Physics. 96 (2016) 2 - p. E140 , 2016

Link: https://doi.org/10.1016/..

13

Changes in Early Urination Control in Relation to Stereotac..:

Wang, J. ; King, C.R. ; Kupelian, P.A....
International Journal of Radiation Oncology*Biology*Physics. 93 (2015) 3 - p. E489-E490 , 2015

Link: https://doi.org/10.1016/..

14

Short and Long-term Toxicity and Cosmesis After Interstitia..:

Kuske, R.R. ; Kamrava, M. ; Chen, P.Y....
International Journal of Radiation Oncology*Biology*Physics. 93 (2015) 3 - p. S60 , 2015

Link: https://doi.org/10.1016/..

15

Is the PTV Margin Important for Local Control in Stage I No..:

Shaverdian, N. ; Wang, J. ; Veruttipong, D....
International Journal of Radiation Oncology*Biology*Physics. 93 (2015) 3 - p. E440 , 2015

Link: https://doi.org/10.1016/..